141 related articles for article (PubMed ID: 7508268)
1. (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
Willner D; Trail PA; Hofstead SJ; King HD; Lasch SJ; Braslawsky GR; Greenfield RS; Kaneko T; Firestone RA
Bioconjug Chem; 1993; 4(6):521-7. PubMed ID: 7508268
[TBL] [Abstract][Full Text] [Related]
2. New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity.
Kaneko T; Willner D; Monkovíc I; Knipe JO; Braslawsky GR; Greenfield RS; Vyas DM
Bioconjug Chem; 1991; 2(3):133-41. PubMed ID: 1932212
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates.
King HD; Yurgaitis D; Willner D; Firestone RA; Yang MB; Lasch SJ; Hellström KE; Trail PA
Bioconjug Chem; 1999; 10(2):279-88. PubMed ID: 10077478
[TBL] [Abstract][Full Text] [Related]
4. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.
Greenfield RS; Kaneko T; Daues A; Edson MA; Fitzgerald KA; Olech LJ; Grattan JA; Spitalny GL; Braslawsky GR
Cancer Res; 1990 Oct; 50(20):6600-7. PubMed ID: 2208122
[TBL] [Abstract][Full Text] [Related]
5. Preparation and functional evaluation of new doxorubicin immunoconjugates containing an acid-sensitive linker on small-cell lung cancer cells.
Froesch BA; Stahel RA; Zangemeister-Wittke U
Cancer Immunol Immunother; 1996 Jan; 42(1):55-63. PubMed ID: 8625367
[TBL] [Abstract][Full Text] [Related]
6. Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins.
Cumber AJ; Westwood JH; Henry RV; Parnell GD; Coles BF; Wawrzynczak EJ
Bioconjug Chem; 1992; 3(5):397-401. PubMed ID: 1329989
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
Sinkule JA; Rosen ST; Radosevich JA
Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
Trail PA; Willner D; Lasch SJ; Henderson AJ; Greenfield RS; King D; Zoeckler ME; Braslawsky GR
Cancer Res; 1992 Oct; 52(20):5693-700. PubMed ID: 1382845
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkages.
Dubowchik GM; Radia S; Mastalerz H; Walker MA; Firestone RA; Dalton King H; Hofstead SJ; Willner D; Lasch SJ; Trail PA
Bioorg Med Chem Lett; 2002 Jun; 12(11):1529-32. PubMed ID: 12031335
[TBL] [Abstract][Full Text] [Related]
10. Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro.
Lau A; Bérubé G; Ford CH; Gallant M
Bioorg Med Chem; 1995 Oct; 3(10):1305-12. PubMed ID: 8564396
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of chimeric BR96-doxorubicin immunoconjugate.
Barbour NP; Paborji M; Alexander TC; Coppola WP; Bogardus JB
Pharm Res; 1995 Feb; 12(2):215-22. PubMed ID: 7784336
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy.
Boga C; Fiume L; Baglioni M; Bertucci C; Farina C; Kratz F; Manerba M; Naldi M; Di Stefano G
Eur J Pharm Sci; 2009 Oct; 38(3):262-9. PubMed ID: 19695327
[TBL] [Abstract][Full Text] [Related]
13. Conjugation of doxorubicin to monoclonal anti-carcinoembryonic antigen antibody via novel thiol-directed cross-linking reagents.
Lau A; Bérubé G; Ford CH
Bioorg Med Chem; 1995 Oct; 3(10):1299-304. PubMed ID: 8564395
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hydrazone heterobifunctional cross-linking agents for reversible conjugation of thiol-containing chemistry.
Christie RJ; Anderson DJ; Grainger DW
Bioconjug Chem; 2010 Oct; 21(10):1779-87. PubMed ID: 20695431
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of conjugates of monoclonal antibodies and staphylococcal enterotoxin A using a new hydrophilic cross-linker.
Akerblom E; Dohlsten M; Brynö C; Mastej M; Steringer I; Hedlund G; Lando P; Kalland T
Bioconjug Chem; 1993; 4(6):455-66. PubMed ID: 8305515
[TBL] [Abstract][Full Text] [Related]
16. Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound.
Kratz F; Warnecke A; Scheuermann K; Stockmar C; Schwab J; Lazar P; Drückes P; Esser N; Drevs J; Rognan D; Bissantz C; Hinderling C; Folkers G; Fichtner I; Unger C
J Med Chem; 2002 Dec; 45(25):5523-33. PubMed ID: 12459020
[TBL] [Abstract][Full Text] [Related]
17. Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.
Braslawsky GR; Kadow K; Knipe J; McGoff K; Edson M; Kaneko T; Greenfield RS
Cancer Immunol Immunother; 1991; 33(6):367-74. PubMed ID: 1878890
[TBL] [Abstract][Full Text] [Related]
18. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
Trail PA; Willner D; Knipe J; Henderson AJ; Lasch SJ; Zoeckler ME; TrailSmith MD; Doyle TW; King HD; Casazza AM; Braslawsky GR; Brown J; Hofstead SJ; Greenfield RS; Firestone RA; Mosure K; Kadow KF; Yang MB; Hellström KE; Hellström I
Cancer Res; 1997 Jan; 57(1):100-5. PubMed ID: 8988048
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol)-doxorubicin conjugates containing beta-lactamase-sensitive linkers.
Senter PD; Svensson HP; Schreiber GJ; Rodriguez JL; Vrudhula VM
Bioconjug Chem; 1995; 6(4):389-94. PubMed ID: 7578358
[TBL] [Abstract][Full Text] [Related]
20. A novel heterobifunctional linker for formyl to thiol coupling.
Heindel ND; Zhao HR; Egolf RA; Chang CH; Schray KJ; Emrich JG; McLaughlin JP; Woo DV
Bioconjug Chem; 1991; 2(6):427-30. PubMed ID: 1725255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
